Mayo Clinic EPC, Rochester MN, USA.
Agency for Healthcare Research and Quality, Rockville MD, USA.
J Clin Epidemiol. 2021 Jul;135:170-175. doi: 10.1016/j.jclinepi.2021.02.028. Epub 2021 Mar 19.
To identify and suggest strategies to make insufficient evidence ratings in systematic reviews more actionable.
A workgroup comprising members from the Evidence-Based Practice (EPC) Program of the Agency for Healthcare Research and Quality convened throughout 2020. We conducted iterative discussions considering information from three data sources: a literature review for relevant publications and frameworks, a review of a convenience sample of past systematic reviews conducted by the EPCs, and an audit of methods used in past EPC technical briefs.
We identified five strategies for supplementing systematic review findings when evidence on benefits or harms is expected to be, or found to be, insufficient: 1) reconsider eligible study designs, 2) summarize indirect evidence, 3) summarize contextual and implementation evidence, 4) consider modelling, and 5) incorporate unpublished health system data in the evidence synthesis. While these strategies may not increase the strength of evidence, they may improve the utility of reports for decision makers. Adopting these strategies depends on feasibility, timeline, funding, and expertise of the systematic reviewers.
Throughout the process of evidence synthesis of early scoping, protocol development, review conduct, and review presentation, authors can consider these five strategies to supplement evidence with insufficient rating to make it more actionable for end-users.
确定并提出策略,使系统评价中证据不足的评级更具可操作性。
一个由医疗保健研究和质量机构的循证实践(EPC)计划成员组成的工作组在 2020 年全年举行了会议。我们进行了迭代讨论,考虑了来自三个信息来源的信息:对相关出版物和框架的文献综述,对 EPC 过去进行的系统评价的方便样本的审查,以及对过去 EPC 技术简报中使用的方法的审核。
当预期或发现收益或危害证据不足时,我们确定了五种补充系统评价结果的策略:1)重新考虑合格的研究设计,2)总结间接证据,3)总结背景和实施证据,4)考虑建模,以及 5)将未发表的卫生系统数据纳入证据综合。虽然这些策略可能不会增加证据的强度,但它们可能会提高报告对决策者的有用性。采用这些策略取决于系统评价者的可行性、时间线、资金和专业知识。
在证据综合的早期范围界定、方案制定、审查进行和审查呈现的整个过程中,作者可以考虑这些五种策略,用证据不足的评级来补充证据,使其更适合最终用户。